文献速递胃肠外科围术期管理与 ERAS

微创与开放间隔减瘤术治疗晚期上皮性卵巢癌的BMI分层分析

Minimally invasive versus open interval debulking surgery for advanced epithelial ovarian cancer: a BMI-stratified analysis.
PubMed 文献 · Surg Endosc · 2026-05-26

本研究纳入256例III-IV期晚期上皮性卵巢癌患者,均接受新辅助化疗后间隔减瘤术,比较开放手术与微创手术(含腹腔镜与机器人辅助)的结局。倾向性评分匹配后两组无进展生存(P=0.379)与总生存(P=0.772)无差异;BMI≥24 kg/m2者微创组术中出血更少、术后排气更早、医源性肠损伤率更低、R0切除率更高,但总生存仍无显著差异。

要点

  • 匹配后微创与开放间隔减瘤术的PFS和OS无显著差异。
  • BMI≥24者微创组术中出血少、排气早、肠损伤少、R0率高。
  • 超重或肥胖患者经仔细选择后微创手术可行且安全。

核心结论

  • 对经仔细选择的超重和肥胖晚期上皮性卵巢癌患者,微创间隔减瘤术是可行且安全的替代方案,围术期有优势且不损害长期肿瘤学结局。

研究设计与样本

  • 回顾性队列研究,纳入2014年3月至2024年3月诊断为III期和IV期晚期上皮性卵巢癌、接受新辅助化疗后间隔减瘤术的患者256例。
  • 患者分为开放手术组与微创手术组(包括腹腔镜和机器人辅助),按体重指数分层比较手术结局。
  • 采用1:1倾向性评分匹配后比较两组结局。

主要发现

  • 倾向性评分匹配后,开放手术组与微创手术组的无进展生存无显著差异(P=0.379)。
  • 倾向性评分匹配后,开放手术组与微创手术组的总生存无显著差异(P=0.772)。
  • 在BMI≥24 kg/m2的患者中,微创组术中出血量低于开放组(P=0.005)。
  • 在BMI≥24 kg/m2的患者中,微创组术后排气时间短于开放组(P=0.020)。
  • 在BMI≥24 kg/m2的患者中,微创组医源性肠损伤率低于开放组(P=0.014),R0切除率高于开放组(P=0.023)。

关键数值与推荐

  • BMI≥24 kg/m2患者中,微创组术中出血量更低(P=0.005)、术后排气时间更短(P=0.020)、医源性肠损伤率更低(P=0.014)、R0切除率更高(P=0.023)。
  • BMI≥24 kg/m2患者中,微创组与开放组总生存无统计学显著差异。

临床怎么用

  • 对经仔细选择的超重或肥胖晚期上皮性卵巢癌患者,可考虑微创间隔减瘤术,围术期获益且长期肿瘤学结局不劣于开放手术。
  • 微创组R0率较高的获益需谨慎解读,因存在选择偏倚。

局限性

  • 微创组R0率较高的获益必须谨慎解读,因存在固有的选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate the surgical outcomes of patients with advanced epithelial ovarian cancer (AEOC) across different body mass index (BMI) levels, who underwent either open surgery or minimally invasive surgery (MIS) for interval debulking surgery (IDS) following neoadjuvant chemotherapy (NACT). METHODS: Patients diagnosed with stage III and IV AEOC between March 2014 and March 2024, who received IDS post-NACT, were enrolled and divided into open and minimally invasive (including laparoscopic and robot-assisted) surgery groups, and stratified by BMI for comparisons of surgical outcomes. RESULTS: A total of 256 patients were enrolled. Following 1:1 propensity score matching, progression-free (PFS, p = 0.379) and overall survival (OS, p = 0.772) did not differ between the open surgery and MIS groups. In patients with BMI ≥ 24 kg/m2, the MIS group had lower intraoperative blood loss (p = 0.005), shorter postoperative flatus time (p = 0.020), lower iatrogenic bowel injury rates (p = 0.014), and higher R0 resection rates (p = 0.023) compared with the open surgery group, but no statistically significant OS difference was observed between MIS and open surgery groups. CONCLUSION: The study suggests that MIS is a feasible and safe alternative for carefully selected overweight and obese patients with AEOC, offering perioperative advantages without compromising long-term oncological outcomes. While MIS was associated with higher R0 rates in this subgroup, the benefits must be interpreted cautiously due to inherent selection biases.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Liu H, Xiao L, Li W, et al. Minimally invasive versus open interval debulking surgery for advanced epithelial ovarian cancer: a BMI-stratified analysis. Surg Endosc. 2026. PMID: 42191958. doi:10.1007/s00464-026-12916-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。